Health Plan Coverage and Contraception

The Wall Street Journal has noted that the Trump administration has taken regulatory action to reduce, if not eliminate (the Supreme Court still has to do its job vis-à-vis a Little Sisters of the Poor case, as does Congress legislatively, contra a short handful of Republicans who prefer Obamacare intact over any step toward getting rid of it), the requirement that health plan providers provide contraception to women at no cost to those women coverees and do so regardless of any question of conscience or religious tenet.

Naturally, Progressive-Democrats and the Left generally have their collective panties in a wedgie over that.  However, they carefully ignore certain inconvenient facts.

One inconvenience is the actual cost of contraception—to the user, not the rest of us who must pay for these “free” items.  Contraceptive pills can be had at places like Walmart for $9/mo, vaginal contraceptives are cheaper, condoms (don’t men have a role here, too?) are $6.50 the dozen.  These are not prices that will shatter anyone’s piggy bank.

Contraceptives are used to treat medical conditions, and they can be terribly expensive?  That’s the other inconvenience.  No they aren’t; those aren’t contraceptives.  They’re medications used for treating a medical condition; they happen to have a (if not the) major side effect of being anti-conceiving.  Insurance plans already covered such meds, and Obamacare could have, too, but the Progressive-Democratic Party eschewed that when they rammed through Obamacare.

In the end, there’s no reason anyone should pay for contraceptives other than the users.  Full stop.

Two Health Insurance Markets?

The Wall Street Journal has misunderstood the situation and the proposal [emphasis added].

President Donald Trump’s executive order on health insurance, the most significant step so far to put his stamp on health policy, is designed to give more options to healthy consumers. It also could divide the insurance market in two.

What Trump is purportedly going to do with his Executive Order is

  • instruct[] federal agencies to loosen rules on health plans that the administration says have driven up premiums and reduced insurance offerings
  • direct the Health and Human Services, Labor, and Treasury Departments to lay the groundwork for the growth of association health plans, coverage that would have fewer mandated benefits than many current plans available to small employers and individuals [and] that wouldn’t be subject to the full range of ACA requirements, such as the mandated package of benefits.
  • departments, in addition, will be told to take steps to expand the availability of short-term medical plans …  allow people to once again buy plans in that category that could last for almost a year.

However, rather than create two health insurance markets, these actions would do no more than begin to create one health insurance market.  There is no extant health insurance market; there is nothing present to become part of “two markets.”  What we have presently is neither insurance nor a market for it.  What we have is a health coverage welfare program that has some (very poor) options from which we’re required to select one for ourselves.

The beginnings of a health insurance market, in addition to being an actual market for health insurance, would, though, lessen the importance of the mandated welfare program—to the benefit of all of us, including those trapped in that welfare program.

Estate Tax and Tax Reform

Senate Republicans seem unable to understand this subject, also.

Others [Republicans] say their desire to eliminate the [estate] tax must be balanced against other priorities including tax cuts for businesses and middle-class families.

This is disingenuous. Eliminating the estate tax explicitly favors middle-class families and businesses: it’s the small businesses and farms that are owned by middle class families that are the most harmed by this death tax.

Aside from that is this piece of irrelevancy:

Estate tax repeal would reduce federal revenue by about $239 billion over the next decade, according to the Tax Policy Center.

Interesting, but unimportant here. Government has yet to show a need for that money.

YGTBSM

This is from a Food and Drug Administration warning letter to the owners of Nashoba Brook Bakery, via The Wall Street Journal:

Your…products are misbranded…because…the labels fail to bear a complete list of all the ingredients by common or usual name….

Your Nashoba Granola label lists ingredient “Love.” Ingredients required to be declared on the label or labeling of food must be listed by their common or usual name…. “Love” is not a common or usual name of an ingredient, and is considered to be intervening material because it is not part of the common or usual name of the ingredient.

The utter idiocy of this bureaucratic foolishness wants no further comment beyond a simple question: why are the letter writer and his supervisor still on the taxpayer’s payroll?  There are other complaints identified in the letter that would appear to be serious, but they’re deprecated, and the letter cannot be taken seriously with this kind of nonsense included.

Another Example

…of government regulatory failure.  The Financial Industry Regulatory Authority, which regulates, among other financial institutions, brokerage houses, has its own investment portfolio.  FINRA charges fees from those it regulates for their privilege of being regulated.  And

In years when FINRA’s fee revenue exceeds forecasts and investment gains are strong, the regulator can rebate fees paid by firms it regulates.

Investment gains are strong.  However, FINRA turns out to be a crappy investor, getting just two-thirds of the return since 2004, when the regulatory body’s investment portfolio was created, that a simple-minded standard portfolio mix of 50% each of bonds and stocks would have gotten in the same period.  Its return shortfall, 3.4% vs that standard portfolio’s 6%, is a real money shortfall: $440 million for a portfolio of $1.6 billion.

And that has real impact on the regulatees that are so privileged: not only have there been no fee rebates since 2014, FINRA is raising fees on its regulatees to make up for its failure as an investor.

Go figure.